Commonwealth Equity Services, LLC Ampio Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $160 - $42,000	-2,000 Reduced 6.34%	29,526 $1,000
Q1 2022 May 04, 2022	SELL	$0.42 - $0.62 $882 - $1,302	-2,100 Reduced 6.25%	31,526 $14,000
Q4 2021 Jan 31, 2022	SELL	$0.56 - $1.71 $1,120 - $3,420	-2,000 Reduced 5.61%	33,626 $19,000
Q2 2021 Aug 11, 2021	BUY	$1.56 - $1.98 $907 - $1,152	582 Added 1.66%	35,626 $59,000
Q4 2020 Feb 11, 2021	BUY	$0.75 - $2.76 $1,500 - $5,520	2,000 Added 6.05%	35,044 $55,000
Q3 2020 Nov 05, 2020	BUY	$0.61 - $1.17 $7,349 - $14,096	12,048 Added 57.38%	33,044 $31,000
Q1 2020 May 11, 2020	BUY	$0.36 - $0.74 $3,094 - $6,361	8,596 Added 69.32%	20,996 $8,000
Q4 2019 Feb 05, 2020	SELL	$0.35 - $0.58 $1,166 - $1,933	-3,334 Reduced 21.19%	12,400 $7,000
Q2 2019 Jul 19, 2019	BUY	$0.39 - $0.7 $2,106 - $3,779	5,400 Added 52.25%	15,734 $6,000
Q1 2019 May 13, 2019	BUY	$0.43 - $0.68 $4,443 - $7,027	10,334 New	10,334 $5,000
Q1 2018 May 14, 2018	SELL	$2.16 - $3.48 $78,939 - $127,180	-36,546 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$0.68 - $4.19 $24,851 - $153,127	36,546	36,546 $149,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.